Skip to main content
OpenTrials
Completed

NCT Number: NCT03037710

Link-HF: Multisensor Non-invasive Telemonitoring System for Prediction of Heart Failure Exacerbation

This is a multi-center, non-randomized, non-interventional study to evaluate the accuracy of a remote monitoring and analytical platform for prediction of heart failure exacerbation. The platform acquires continuous multivariate vital signs from HF patients using a new ambulatory wearable (attached by an adhesive) multi-sensor device and analyzes the data using a novel machine learning algorithm.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Palo Alto VA Health Care System, Palo Alto, California, United States

Loading trial locations.

About this study

The analytics being investigated includes a Similarity-Based Modeling technique, that empirically estimates the expected physiological behavior of a subject based on prior learned dynamic data, for comparison to actual measured behavior from the subject, to reveal discrepancies hidden by normal variation. The measurements are typically an ensemble of vital signs that effectively characterizes the physiological "control system" of the subject. This technique is multivariate: multiple variables are leveraged, because single variables in isolation have little context - a high heart rate by itself could mean a person is exerting himself, or it could mean his physiology is in distress even though he is not exerting himself. With reference to several other variables, however, such as respiration rate, oximetry and motion/activity, a high heart rate might be recognized as a normal state when accompanied by the corroborating data showing a high respiration rate, a normal oximetry and a high level of motion - the person is exercising.

A wearable adhesive multi-sensor device will be used to collect continuous vital sign and other data from study subjects, including heart rate, respiration rate, bodily motion/activity, skin temperature, pulse, electrocardiogram and peripheral capillary oxygen saturation. Subjects are provided with a smartphone or cellular tablet that will be paired with the multi-sensor device to receive data and upload it to the analytics server via cellular network or WiFi internet. Study staff will interact with the subject during visits scheduled for routine heart failure follow-up to capture pre-specified heart failure medical events. All standard of care clinic and hospitalization notes and procedure reports including echocardiograms, right heart catheterizations, pulmonary function tests, six minute walk tests and radiology reports will be collected as they occur.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject must be 18 years old or older
  • NYHA( New York Heart Association Functional Classification) Class II-IV, documented in site's medical record system.
  • Subject able and willing to sign Informed Consent Document.
  • Subject willing and able to perform all study related procedures.

Exclusion criteria

  • Expected LVAD (Left Ventricular Assist Device) implantation or heart transplantation in the next 30 days.
  • Skin damage or significant arthritis, preventing wearing of device.
  • Uncontrolled seizures or other neurological disorders leading to excessive abnormal movements or tremors in the upper body.
  • Pregnant women or those who are currently nursing.
  • Visual/cognitive impairment that as judged by the investigator does not allow the subject to independently follow rules and procedures of the protocol.

Treatment and study plan

HealthPatch

Device

A multi-sensor device to collect continuous vital signs

Primary outcomes

  1. Detection of Heart Failure Exacerbation Event

    Time frame: 90 Days

    Correlation of algorithmic alerts generated by a non-invasive telemonitoring system to a verified heart failure exacerbation event, measured in percent accuracy

Sponsors and collaborators

Lead sponsor

Josef Stehlik

Other

Registry information

Acronym: LINK-HF

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Jan 31, 2017
Registry last updated
Aug 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.